Grants and Contributions:
Title:
Market research and technology development for eye3’s next generation, point-of-contact drugs of abuse testing system
Agreement Number:
992525
Agreement Value:
$75,000.00
Agreement Date:
Jul 1, 2022 - Mar 31, 2023
Description:
In this project eye3 will test and advance development of its handheld drugs of abuse testing system, including usability testing of the Alpha prototype with potential customers. The goal of the usability testing is to obtain usability and performance feedback to further the R&D of the system, as well as get market insights to assist eye3 in defining how to best position and promote the system.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Burlington, Ontario, CA L7L 1E1
Reference Number:
172-2022-2023-Q2-992525
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
820205284
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 31 days. The total amended value is 35,700 dollars.
Amendment Date
Dec 8, 2022
Recipient's Operating Name:
eye3
Recipient's Legal Name:
eye3concepts Inc.
Federal Riding Name:
Burlington
Federal Riding Number:
35015
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
334512
Amendments: